recombinant factor VIII (Pharming/SIPI)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug Namerecombinant factor VIII (Pharming/SIPI)
Drug Alias Namerecombinant factor VIII (Pharming)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionCoagulation factor VIII stimulants
TargetsCoagulation factor VIII
Therapy Area/IndicationsHemophilia A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlandsMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesPharming Group Nv
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharming Group NvState Pharmaceutical Administration of Shanghai Institute of Pharmaceutical Industry
Active IndicationsN/A
Inactive IndicationsHemophilia A

Other Information

ATC CodeN/A
Related LinksN/A